HopeStage
Back to all studies
CompletedNCT00182520

Topiramate added to usual treatment for persistent obsessive-compulsive symptoms

About this title

Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)

Read the official source — NCT00182520

Researchers compared Topiramate and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Medication studyAges 18–65Canada
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Topiramate and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
HamiltonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2002
Recruitment status
Completed
Enrollment listed in the registry
23
Sponsor
McMaster University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00182520
Official title
Show the full official title

A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Hamilton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Topiramate and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who is behind this study?

The study sponsor is McMaster University, a university.

Did this study involve medication?

Yes. The study involved medication, including Topiramate and placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies